Enrique Poradosu - Nov 19, 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chief Science & Business Off
Signature
/s/ Enrique Poradosu
Stock symbol
NVCT
Transactions as of
Nov 19, 2024
Transactions value $
$9,980
Form type
4
Date filed
11/20/2024, 08:30 AM
Previous filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $9.98K +2K +0.13% $4.99 1.51M Nov 19, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $4.98 to $4.99. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Includes 353,399 shares of restricted stock.